Globeimmuneincis A Biopharmaceutical Company Established In 1995Originally Known As Ceres Pharmaceuticalsincthe Company Focuses On Developing Therapeutic Products For Cancer And Infectious Diseases Using Its Proprietary Tarmogenaplatformthis Platform Aims To Stimulate The Immune System To Recognize And Attack Diseased Cells Globeimmune Engages In Research And Development Activities To Create Innovative Treatmentsthe Company Has Formed Strategic Collaborations With Major Pharmaceutical Firmsincluding Gilead Sciencesincand Celgene Corporationnow Part Of Bristol Myers Squibbthese Partnerships Support Globeimmune S Commitment To Advancing Its Research And Development Efforts In The Biopharmaceutical Field
